MedTrace Logo

Non-invasive Ventilation System in Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

NCT01355978 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2016-10-12

Study results available
· View outcomes & findings →

Summary

When using the Breathe Technologies Ventilation System during simulated activities of daily living (ADLs), Subjects with moderate-to-severe chronic obstructive pulmonary Disease (COPD) will be comfortable and report acceptability.

Conditions

  • Pulmonary Disease, Chronic Obstructive
  • Airflow Obstruction, Chronic
  • Chronic Obstructive Airway Disease
  • Chronic Obstructive Lung Disease

Interventions

DEVICE

Noninvasive Open Ventilation System

Noninvasive ventilation system

Sponsors & Collaborators

  • Breathe Technologies, Inc.

    lead INDUSTRY

Principal Investigators

  • Richard Kops, MD · John Muir Health

  • Lynn McCabe, RRT, RCP · Sharp HealthCare

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2011-10-31
Completion
2011-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01355978 on ClinicalTrials.gov